Hairy Cell Leukemia
📧 Sign up to get email alerts when something new happens for Hairy Cell Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
NCI-sponsored clinical trial update describes collecting human samples to study hairy cell leukemia and other leukemias, and to develop reco…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People With Hairy Cell Leukemia (HCL) [Phase 2]
A Phase 2 clinical trial evaluating the combination of vemurafenib and obinutuzumab versus cladribine and rituximab in hairy cell leukemia, …
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Testing the Combination of Anti-cancer Drugs, Tovorafenib Plus Rituximab, in Patients With Hairy Cell Leukemia [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study evaluating the combination of tovorafenib with rituximab in patients with hairy cell …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia [Phase 2]
This update describes an ongoing Phase 2 trial of ibrutinib for relapsed hairy cell leukemia and hairy cell leukemia variant. The study is c…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Phase I Study of Anti-CD22 Chimeric Receptor T Cells in Patients With Relapsed/Refractory Hairy Cell Leukemia and Variant [Phase 1]
Phase I clinical trial evaluating anti-CD22 CAR-T cells in patients with relapsed/refractory hairy cell leukemia and hairy cell leukemia var…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Binimetinib for People With Relapsed/Refractory BRAF Wild Type Hairy Cell Leukemia and Variant [Phase 2]
This clinical trial update notes a Phase 2 study evaluating binimetinib for relapsed/refractory BRAF wild-type hairy cell leukemia and its v…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Encorafenib Plus Binimetinib for People With BRAF V600 Mutated Relapsed/Refractory HCL [Phase 2]
This clinical trial update reports a Phase 2 study of encorafenib plus binimetinib for BRAF V600-mutated hairy cell leukemia, which is curre…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies. [Phase 1]
A Phase 1 clinical trial evaluating oral LP-168 in relapsed or refractory B-cell malignancies is recruiting. Target conditions include CLL/S…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: A Phase II Study of the BRAF Inhibitor, Vemurafenib, Plus Obinutuzumab in Patients With Previously Untreated Classical Hairy Cell Leukemia [Phase 2]
A Phase II trial is evaluating the combination of vemurafenib and obinutuzumab in patients with previously untreated classical hairy cell le…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies [Phase 1]
MacroGenics reports a Phase 1 study of MGD024 in relapsed or refractory hematologic malignancies is currently recruiting across multiple dis…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia [Phase 2]
A Phase 2 clinical trial update describes evaluating the combination of cladribine and rituximab for hairy cell leukemia, currently recruiti…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas [Phase 1]
Phase 1 clinical trial evaluating autologous CD22-directed CAR-T cells in patients with recurrent or refractory B-cell lymphomas, including …
-
CLINICAL_TRIALS research · 2025-04-16Clinical Trial Update: Hairy Cell Leukemia Patient Data Registry
A clinical trial update for a Hairy Cell Leukemia patient data registry sponsored by Ohio State University Comprehensive Cancer Center. The …
-
CLINICAL_TRIALS research · 2025-01-17Clinical Trial Update: Assessment of Disease Burden in Hairy Cell Leukemia [NA]
A clinical trial is assessing disease burden in hairy cell leukemia and is currently recruiting at a sponsor site.
-
CLINICAL_TRIALS research · 2025-01-14Clinical Trial Update: Decoding the Extracellular Vesicles-driven Communication in the Microenvironment of Hairy Cell Leukemia to Improve Patient Care Management
A clinical trial investigating how extracellular vesicles mediate communication in the microenvironment of Hairy Cell Leukemia to improve pa…
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: Hairy Cell Leukemia: Harnessing the Full Power of Extracellular Vesicles to Improve Patient Care Management
A clinical trial investigating extracellular vesicle-based strategies for Hairy cell leukemia is currently recruiting. The study aims to har…
-
CLINICAL_TRIALS research · 2024-08-22Clinical Trial Update: Therapy Optimisation for the Treatment of Hairy Cell Leukemia [Phase 2, Phase 3]
A clinical trial update for therapy optimisation in hairy cell leukemia is in Phase 2/3 and currently recruiting.
-
CLINICAL_TRIALS research · 2016-08-30Clinical Trial Update: Rituximab in Hairy Cell Leukemia: a Multicenter Retrospective Study
A multicenter retrospective study evaluates the use of rituximab in hairy cell leukemia.